LEVETIRACETAM (UK) 500MG is a second-generation antiepileptic medication designed to control seizures in adults and children with epilepsy. This extended-release tablet formulation provides steady plasma levels of the active ingredient, levetiracetam, ensuring consistent seizure suppression throughout the day. Clinically proven to reduce the frequency and severity of partial-onset seizures, LETROZOLE DENK is a preferred choice for patients and neurologists seeking reliable, long-term seizure management with minimal side effects.